PI
TEVA icon

PEAK6 Investments’s Teva Pharmaceuticals TEVA Stock Holding History

PEAK6 Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$360K Buy
+20,000
New +$350K ﹤0.01% 2500
2023
Q3 		– Sell
-300
Closed -$2.26K – 4581
2023
Q2 		$2.26K Sell
300
-94,600
-100% -$767K ﹤0.01% 3722
2023
Q1 		$840K Sell
94,900
-200,100
-68% -$1.98M ﹤0.01% 1976
2022
Q4 		$2.69M Sell
295,000
-55,000
-16% -$480K 0.02% 1118
2022
Q3 		$2.82M Buy
350,000
+249,700
+249% +$2.21M 0.01% 1263
2022
Q2 		$754K Sell
100,300
-81,100
-45% -$707K ﹤0.01% 3366
2022
Q1 		$1.7M Sell
181,400
-231,300
-56% -$1.93M ﹤0.01% 2011
2021
Q4 		$3.31M Hold
412,700
– – 0.01% 1462
2021
Q3 		$4.02M Sell
412,700
-32,900
-7% -$308K 0.01% 1324
2021
Q2 		$4.41M Buy
445,600
+400,000
+877% +$4.23M 0.01% 1210
2021
Q1 		$526K Sell
45,600
-20,900
-31% -$240K ﹤0.01% 3151
2020
Q4 		$642K Hold
66,500
– – ﹤0.01% 2874
2020
Q3 		$599K Hold
66,500
– – ﹤0.01% 2691
2020
Q2 		$820K Sell
66,500
-8,000
-11% -$90.5K ﹤0.01% 2269
2020
Q1 		$669K Buy
74,500
+55,000
+282% +$563K ﹤0.01% 1846
2019
Q4 		$191K Sell
19,500
-154,400
-89% -$1.38M ﹤0.01% 2572
2019
Q3 		$1.2M Buy
173,900
+26,400
+18% +$202K 0.01% 1623
2019
Q2 		$1.36M Sell
147,500
-372,300
-72% -$4.49M 0.01% 1573
2019
Q1 		$8.15M Buy
519,800
+405,900
+356% +$7.16M 0.05% 459
2018
Q4 		$1.76M Buy
113,900
+56,000
+97% +$1.15M 0.01% 1332
2018
Q3 		$1.25M Buy
+57,900
New +$1.34M 0.01% 1815

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PEAK6 Investments's TEVA Position: Q3 2024 in Review

PEAK6 Investments reduced its Teva Pharmaceuticals (TEVA) stake by 48% in Q3 2024, selling an estimated $484K and leaving 30,000 shares worth $541K. The position accounts for ﹤0.01% of the portfolio, ranked #2267.

PEAK6 Investments first reported a position in TEVA in Q3 2018 and has held it in 22 quarters since. The position peaked at $6.8M in Q3 2022. 543 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • PEAK6 Investments held 30,000 shares of Teva Pharmaceuticals worth $541K as of Q3 2024.
  • PEAK6 Investments sold 27,666 Teva Pharmaceuticals shares in Q3 2024, an estimated $484K.
  • Teva Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2267 holding.
  • PEAK6 Investments first reported a position in Teva Pharmaceuticals in Q3 2018 and has held it in 22 quarters since.
  • PEAK6 Investments's Teva Pharmaceuticals position peaked at $6.8M in Q3 2022.
  • 543 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.